Pharmacokinetic study of long-acting oxytetracycline in cows

被引：0

作者：

SanMartin, B ^{[1
]}

Lagos, R ^{[1
]}

Gai, MN ^{[1
]}

机构：

[1] UNIV CHILE,FAC CIENCIAS QUIM & FARMACEUT,LAB CIENCIAS & TECNOL FARMACEUT,SANTIAGO,CHILE

来源：

ARCHIVOS DE MEDICINA VETERINARIA | 1996年 / 28卷 / 02期

关键词：

pharmacokinetics; oxytetracycline; long-acting;

D O I：

暂无

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

Pharmacokinetics of a long-acting formula of oxytetracycline (OTC) in one formulation of dymetylacetomide, was studied in seven cows after i.m. administration (20 mg/kg of body weight). Serum OTC concentration was measured using a microbiological assay procedure with a sensibility of 0.312 mu g/ml. The mean residence time (MRT) was 20.68+/-5.55 h and the half life was 9.63+/-4.04 h. The maximal OTC concentration (7.53+/-2.20 mu g/ml) was observed after 8.42+/-3.43 h. Serum concentration >1 mu g/ml was maintained for about 39.57+/-13.15 hours.

引用

页码：19 / 25

页数：7

共 50 条

[41] Long-acting octreotide and prolonged-release lanreotide formulations have different pharmacokinetic profiles
Astruc, B
Marbach, P
Bouterfa, H
Denot, C
Safari, M
Vitaliti, A
Sheppard, M
JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (07): : 836 - 844
[42] Semaglutide - Pharmacodynamic and Pharmacokinetic Characteristics of a New Long-Acting GLP-1-Receptor Agonist
Nauck, Michael A.
Gallwitz, Baptist
Seufert, Jochen
DIABETOLOGIE UND STOFFWECHSEL, 2017, 12 (02) : 135 - 140
[43] Long-acting risperidone - A review of its use in schizophrenia
Harrison, TS
Goa, KL
CNS DRUGS, 2004, 18 (02) : 113 - 132
[44] Long-Acting Risperidone: A Review of Its Use in Schizophrenia
Harrison T.S.
Goa K.L.
CNS Drugs, 2004, 18 (2) : 113 - 132
[45] Clinical experience and management considerations with long-acting risperidone
Parellada, E
CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (02) : 241 - 255
[46] Pharmacokinetics assessment of moxidectin long-acting formulation in cattle
Dupuy, J.
Sutra, J. F.
Alvinerie, M.
VETERINARY PARASITOLOGY, 2007, 147 (3-4) : 252 - 257
[47] Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection
Citrome, Leslie
PATIENT PREFERENCE AND ADHERENCE, 2009, 3 : 345 - 355
[48] Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir-rilpivirine in clinical practice
Borghetti, Alberto
Farinacci, Damiano
Ciccullo, Arturo
Dusina, Alex
Moschese, Davide
Iannone, Valentina
D'Angelillo, Anna
Lombardi, Francesca
Delle Donne, Valentina
Massaroni, Valentina
Visconti, Elena
Tamburrini, Enrica
Di Giambenedetto, Simona
JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (10) : 4970 - 4974
[49] Long-Acting Treatments for Hepatitis B
Thomas, David L.
Kiser, Jennifer J.
Baum, Marc M.
CLINICAL INFECTIOUS DISEASES, 2022, 75 : S517 - S524
[50] Long-Acting Growth Hormone: An Update
Saenger, Paul H.
Mejia-Corletto, Jorge
ADVANCED THERAPIES IN PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY, 2016, 30 : 79 - 97

← 1 2 3 4 5 →